Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crocus | 3 | 2024 | 20 | 2.000 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 92 | 0.880 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2024 | 149 | 0.850 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 441 | 0.640 |
Why?
|
| Histones | 3 | 2021 | 190 | 0.510 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.420 |
Why?
|
| Histone Code | 2 | 2022 | 13 | 0.400 |
Why?
|
| Plant Extracts | 2 | 2024 | 286 | 0.360 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2024 | 31 | 0.240 |
Why?
|
| Microsatellite Repeats | 1 | 2024 | 59 | 0.240 |
Why?
|
| Phytotherapy | 1 | 2024 | 81 | 0.230 |
Why?
|
| Microsatellite Instability | 1 | 2024 | 43 | 0.230 |
Why?
|
| Liver Diseases | 1 | 2023 | 33 | 0.230 |
Why?
|
| Crohn Disease | 1 | 2024 | 63 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 42 | 0.220 |
Why?
|
| Virulence | 1 | 2024 | 223 | 0.220 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2020 | 37 | 0.220 |
Why?
|
| Biological Products | 1 | 2023 | 71 | 0.210 |
Why?
|
| Sirtuin 1 | 1 | 2022 | 32 | 0.210 |
Why?
|
| Histone Chaperones | 1 | 2021 | 2 | 0.200 |
Why?
|
| Hospital Mortality | 1 | 2023 | 187 | 0.200 |
Why?
|
| Humans | 10 | 2024 | 37093 | 0.200 |
Why?
|
| Antioxidants | 1 | 2024 | 416 | 0.190 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 219 | 0.190 |
Why?
|
| Cytokines | 1 | 2024 | 602 | 0.180 |
Why?
|
| Databases, Protein | 1 | 2020 | 48 | 0.180 |
Why?
|
| Histone Deacetylase 1 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Hospitalization | 1 | 2023 | 388 | 0.180 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 92 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 145 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 229 | 0.170 |
Why?
|
| DNA | 1 | 2022 | 574 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 190 | 0.170 |
Why?
|
| Software | 1 | 2020 | 217 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 938 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 195 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2021 | 681 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 643 | 0.130 |
Why?
|
| Animals | 4 | 2024 | 15081 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 935 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 803 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 13 | 0.060 |
Why?
|
| Vomiting | 1 | 2023 | 14 | 0.060 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2023 | 28 | 0.060 |
Why?
|
| Rats | 2 | 2021 | 3483 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2023 | 224 | 0.060 |
Why?
|
| Prostate | 1 | 2023 | 154 | 0.050 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 356 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2021 | 100 | 0.050 |
Why?
|
| Mice | 2 | 2023 | 5913 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 974 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 173 | 0.050 |
Why?
|
| Comorbidity | 1 | 2023 | 623 | 0.050 |
Why?
|
| Male | 3 | 2023 | 20025 | 0.050 |
Why?
|
| Chromatin | 1 | 2021 | 169 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 539 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 12 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 37 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 43 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2020 | 29 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 98 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1378 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 82 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 130 | 0.040 |
Why?
|
| Cell Death | 1 | 2020 | 267 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1455 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 173 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2021 | 325 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 293 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2026 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 2379 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 807 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 3562 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1015 | 0.030 |
Why?
|
| Female | 2 | 2023 | 20969 | 0.030 |
Why?
|
| Aged | 1 | 2023 | 6741 | 0.020 |
Why?
|
| Middle Aged | 1 | 2023 | 10129 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 11712 | 0.020 |
Why?
|